Please login to the form below

Not currently logged in
Email:
Password:

Pharma must step up monitoring of social media

New service intends to help keep track of online patient communications

Social media has been a rising point of concern for pharma companies with regards to the monitoring of patient communications about drug safety, but a new service could help track online activities.

Patient reports have been notoriously hard to rack on tools such as Facebook and Twitter, leading to such regulatory concerns such as Roche last year, with the Swiss pharma company found to have “serious shortcomings” with regards to pharmacovigilance practices following an investigation by the European Medicines Agency (EMA).

Life sciences consulting company YourEncore says its new service to track social media communications – which evolved from previous work with a pharma company - could help avert future regulatory breaches such as those committed by Roche.

“Drug makers may have hundreds of patient outreach programmes worldwide gathering patient safety information every day without the required regulatory controls,” said Pam Holland, YourEncore's managing director, life sciences.

“We help ensure that all past and future safety information is handled according to the law.”

The service was developed after YourEncore experts visit an unnamed pharma firm's operations across more than 20 countries, reviewing its patient outreach programmes in order to identify shortcomings and enhance reporting standards.

Regulatory agencies are also doing more to help pharma companies comply with the pharmacovigilance rules amid the rise of online technologies.

This includes the publication at the start of the year of draft FDA guidance on 'interactive promotional media', encompassing Twitter, Facebook and blogs.

Article by
Tara Craig

2nd April 2014

From: Marketing, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy...

Infographics